![]() Complexa Complexa is a biopharmaceutical company, developing therapies for the treatment of inflammatory, and metabolic diseases. | ![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ![]() Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. | ||
Founding Date | Founding Date 2008 | Founding Date N/A | Founding Date 2001 | Founding Date 2014 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Berwyn, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Utrecht, NL HQ Utrecht, NL | Locations San Diego, US HQ |
Employees | Employees 9 | Employees 29723% increase | Employees 28 | Employees 3939% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) N/A | Valuation ($) 2.2 b |
Financial | ||||
Net income | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income N/A | Net income ($5.9m) (FY, 2017) |
Funding | ||||
Latest funding round | Latest funding round $ 62m (almost 9 years ago) | Latest funding round N/A | Latest funding round $ 24m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 79m | Total funding raised $ 267.3m | Total funding raised $ 210.3m | Total funding raised $ 79m |

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companyAM-Pharma is a biopharmaceutical company that develops medicines for patients.
View company
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View company